Literature DB >> 15033716

Prodigiosin induces apoptosis by acting on mitochondria in human lung cancer cells.

Esther Llagostera1, Vanessa Soto-Cerrato, Beatriz Montaner, Ricardo Pérez-Tomás.   

Abstract

Prodigiosin (PG) is a secondary metabolite, isolated from a culture of Serratia marcescens, which has shown potent cytotoxicity against various human cancer cell lines as well as immunosuppressive activity. The purpose of this study was to evaluate the role of mitochondria in PG-induced apoptosis. Therefore, we evaluated the apoptotic action of PG in GLC4 small cell lung cancer cell line by Hoechst 33342 staining. In these cells, we examined mitochondrial apoptosis-inducing factor (AIF) and cytochrome c (cyt c) release to the cytosol in PG time-response studies. These findings suggest that PG induces apoptosis in both caspase-dependent and caspase-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15033716     DOI: 10.1196/annals.1299.030

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  RedH and PigC Catalyze the Biosynthesis of Hybrubins via Phosphorylation of 4'-Methoxy-2,2'-Bipyrrole-5'-Carbaldehyde.

Authors:  Qingshan Long; Daniel E Jeffries; Shuangjun Lin; Xuefei Chen; Weijun He; Yemin Wang; Zixin Deng; Craig W Lindsley; Meifeng Tao
Journal:  Appl Environ Microbiol       Date:  2020-01-07       Impact factor: 4.792

2.  Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.

Authors:  Rahul K Suryawanshi; Lulia Koujah; Chandrashekhar D Patil; Joshua M Ames; Alex Agelidis; Tejabhiram Yadavalli; Satish V Patil; Deepak Shukla
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  A 2-substituted prodiginine, 2-(p-hydroxybenzyl)prodigiosin, from Pseudoalteromonas rubra.

Authors:  Domonkos Fehér; Russell S Barlow; Patricia S Lorenzo; Thomas K Hemscheidt
Journal:  J Nat Prod       Date:  2008-10-15       Impact factor: 4.050

4.  Unusual odd-electron fragments from even-electron protonated prodiginine precursors using positive-ion electrospray tandem mass spectrometry.

Authors:  Kan Chen; Nalaka S Rannulu; Yang Cai; Pat Lane; Andrea L Liebl; Bernard B Rees; Christophe Corre; Gregory L Challis; Richard B Cole
Journal:  J Am Soc Mass Spectrom       Date:  2008-08-09       Impact factor: 3.109

5.  Mitochondrial dysfunction in Trypanosoma cruzi: the role of Serratia marcescens prodigiosin in the alternative treatment of Chagas disease.

Authors:  Carlos Genes; Eduard Baquero; Fernando Echeverri; Juan D Maya; Omar Triana
Journal:  Parasit Vectors       Date:  2011-05-06       Impact factor: 3.876

Review 6.  Biotechnological Activities and Applications of Bacterial Pigments Violacein and Prodigiosin.

Authors:  Seong Yeol Choi; Sungbin Lim; Kyoung-Hye Yoon; Jin I Lee; Robert J Mitchell
Journal:  J Biol Eng       Date:  2021-03-11       Impact factor: 4.355

7.  Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy.

Authors:  Dijie Zheng; Shiyu Chen; Kun Cai; Linhan Lei; Chunchen Wu; Chengyi Sun; Yazhu Deng; Chao Yu
Journal:  Cancer Cell Int       Date:  2021-12-09       Impact factor: 5.722

Review 8.  Production and Potential Applications of Bioconversion of Chitin and Protein-Containing Fishery Byproducts into Prodigiosin: A Review.

Authors:  San-Lang Wang; Van Bon Nguyen; Chien Thang Doan; Thi Ngoc Tran; Minh Trung Nguyen; Anh Dzung Nguyen
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

9.  PG-Priming Enhances Doxorubicin Influx to Trigger Necrotic and Autophagic Cell Death in Oral Squamous Cell Carcinoma.

Authors:  Shian-Ren Lin; Ching-Feng Weng
Journal:  J Clin Med       Date:  2018-10-21       Impact factor: 4.241

10.  Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer.

Authors:  Wei-Jun Chiu; Shian-Ren Lin; Yu-Hsin Chen; May-Jwan Tsai; Max K Leong; Ching-Feng Weng
Journal:  J Clin Med       Date:  2018-10-03       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.